Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
As part of the Pediatric Research Equity Act (PREA) commitment, the objectives of the study
are to characterize the pharmacokinetic (PK) profile and to determine the safety and
tolerability of diclofenac potassium oral solution in pediatric subjects experiencing mild to
moderate acute pain.